Medical Disclaimer: Compounded GLP-1 medications (semaglutide, tirzepatide) are not FDA-approved; they are produced by state-licensed 503A or 503B compounding pharmacies under patient-specific prescriptions. Branded products (Wegovy, Zepbound, Mounjaro, Ozempic) are FDA-approved for specific indications. Content on GLP1CompareHub is educational and is not medical advice — consult a licensed prescriber before starting, stopping, or modifying any GLP-1 medication. Full medical disclaimer.
OrderlyMeds vs MEDVi (2026): Why MEDVi Is the Clear Choice
MEDVi enters this comparison with confirmed pricing ($179–$299/mo), physician supervision, and over 33,000 monthly branded searches. OrderlyMeds is an emerging provider with no confirmed pricing. The winner here is straightforward — but we’ll walk through the full picture.
OrderlyMeds pricing is unconfirmed
We could not independently verify OrderlyMeds’ current pricing. All OrderlyMeds price cells below are marked VERIFY. Visit their site directly before making any enrollment decision.
Head-to-Head Comparison
| Feature | OrderlyMeds | MEDVi |
|---|---|---|
| Monthly Price | VERIFY | $179–$299/mo |
| Medication Options | Compounded GLP-1 | Compounded sema + tirz |
| Consultation | VERIFY | Telehealth physician intake |
| Ongoing Support | VERIFY | Included in program |
| Brand Recognition | Emerging / lower | Strong (33K+ mo. searches) |
| Best For | VERIFY FIRST | Budget-conscious, price-transparent GLP-1 seekers |
Our Verdict: MEDVi Wins Clearly
MEDVi is the straightforward winner in this matchup. It offers confirmed pricing from $179/mo, a well-documented telehealth program with physician supervision, compounded semaglutide and tirzepatide options, and over 33,000 monthly branded searches that signal real consumer trust.
OrderlyMeds has no confirmed pricing data — making it impossible to evaluate on cost transparency, a key factor when choosing a monthly subscription program.
Bottom line: Choose MEDVi if you want a verified price, established brand, and physician-supervised GLP-1 program. If you still want to explore OrderlyMeds, verify pricing directly before committing.
OrderlyMeds
Emerging compounded GLP-1 telehealth
- GLP-1 telehealth platform
- All pricing unconfirmed — verify directly
- Lower brand recognition than MEDVi
- No confirmed program structure data
MEDVi
Editor’s PickEstablished compounded GLP-1 provider
- Confirmed pricing: $179–$299/mo
- Compounded semaglutide and tirzepatide
- Physician-supervised telehealth intake
- 33K+ monthly branded searches
Why 33,000+ Monthly Searches Matters
MEDVi receives over 33,000 branded searches per month — meaning consumers are actively seeking them out by name. That level of organic brand demand typically reflects a real patient base, established reputation, and longer operating history.
OrderlyMeds does not have comparable brand search volume, which means less publicly available patient feedback and a harder-to-verify track record. This is not a disqualifier, but it’s a meaningful signal when you’re evaluating a monthly medical subscription.
Frequently Asked Questions
How much does MEDVi cost per month?
MEDVi pricing starts at approximately $179/month at the entry level, with higher tiers up to ~$299/month. This range is confirmed through independent verification.
How much does OrderlyMeds cost per month?
OrderlyMeds pricing is not independently confirmed. Visit their site directly to see current pricing before enrolling.
Is MEDVi better than OrderlyMeds?
Yes, based on available data MEDVi is the stronger choice. MEDVi has confirmed pricing ($179–$299/mo), 33,000+ monthly branded searches indicating established brand trust, and physician-supervised compounded semaglutide and tirzepatide. OrderlyMeds lacks confirmed pricing data.
Does MEDVi offer compounded tirzepatide?
Yes, MEDVi offers both compounded semaglutide and compounded tirzepatide through its telehealth platform. Pricing may vary by medication type — verify the specific plan on their site.
Is MEDVi physician-supervised?
Yes, MEDVi uses licensed physicians for intake and ongoing supervision of GLP-1 prescriptions. Their program is structured around telehealth consultations.
Why does MEDVi have 33,000+ monthly searches?
MEDVi has built strong brand recognition in the compounded GLP-1 space, resulting in over 33,000 monthly branded searches. This level of consumer awareness typically reflects real patient volume and a longer operating track record.